Coming soon: news from HIVR4P and HIV Glasgow conferences

Amelia Jones
Published: 12 October 2016

Later this month, NAM will be reporting from two international HIV conferences – HIV Research for Prevention (HIVR4P) and the International Congress on Drug Therapy in HIV Infection (HIV Glasgow).

HIVR4P

HIVR4P is being held in Chicago, USA from 17-21 October.

The conference is dedicated to biomedical HIV prevention research, including vaccines, microbicides, pre-exposure prophylaxis (PrEP) and treatment as prevention.

We will be reporting on key research presented at the conference, publishing news online at www.aidsmap.com/HIVR4P-2016 and sending out one conference bulletin (in English) the week following the conference. You can sign up here to receive the bulletin. (If you already subscribe to one of our regular news bulletins, you will automatically receive this conference bulletin.)

For more information on the conference, visit the official conference website hivr4p.org and view the online conference programme.

HIV Glasgow

HIV Glasgow is taking place from 23-26 October in Glasgow, UK.

NAM is the official provider of online science news for the conference.

Among the highlights of the conference there will be new research on:

  • PrEP implementation
  • Simplified two-drug regimens for long-term treatment
  • Use of generic drugs for treatment of HIV and hepatitis C
  • New antiretroviral agents for treatment-experienced people
  • Tolerability of newer antiretroviral drugs
  • New models of HIV care
  • Co-morbidities, including cancers and tuberculosis.

For more information, visit the official conference website at hivglasgow.org and view the online scientific programme.

We will be publishing news online at www.aidsmap.com/HIV-Glasgow-2016 and sending out a round-up of news in a summary bulletin the week after the conference. This bulletin will be available in English, French, Italian, Portuguese, Russian and Spanish. (As above, you will receive this bulletin automatically if you already subscribe to our regular news bulletins.)

NAM will have a stand in the exhibition hall at HIV Glasgow. So if you are attending the conference, please drop by to say hello!

Sharing knowledge, changing lives

NAM works to change lives by sharing information about HIV and you can help by sharing links to the research presented at the conferences. So please feel free to use links to our news stories, bulletins and any other aidsmap.com pages – in emails, newsletters and blogs or in other social media like Facebook and Twitter.

Want to keep up to date with the latest aidsmap news? Download our free app

You can also access news from the conferences through our free news app for iPhone or Android. The apps will link to our daily news reports on new research presented at the conferences, and other news on HIV treatment and prevention. We also cover key developments in hepatitis, TB and other health conditions linked to HIV.

As well as articles by our own editors, the apps include a daily hand-picked selection of HIV-related stories from other websites around the world.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.